コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 utcomes), by risk classification (low or not low risk).
2 reatography (intermediate risk), or no test (low risk).
3 8 with non-null mutations were classified as low risk.
4 hout alcohol were perceived as situations of low risk.
5 increase in CVD events compared to those at low risk.
6 ort studies, 2825 (30.6%) were classified as low risk.
7 ocated 0-Is or 0-IIa granular lesions have a low risk.
8 set showed similar rates of CNS disease for low-risk (0.8%; CI, 0.0% to 1.6%), intermediate-risk (3.
9 osts were $9506 for practices categorized as low risk, $13683 for high medical risk only, $8214 for h
10 to high-risk (26%), standard-risk (29%), and low-risk (45%) groups, with different lengths of overall
11 es were delineated, with 5-year OS of 91% in low-risk, 66% in intermediate-risk (HR, 3.2; 95% CI, 1.9
12 for the MIPSS70 model; 5-year OS was 95% in low-risk, 70% in intermediate-risk, and 29% in high-risk
13 follow guidelines to survey individuals with low-risk adenomas (LRAs; 1-2 small tubular adenomas, < 1
14 = 1016), high-risk adenomas (HRA, n = 817), low-risk adenomas (n = 1418), and no adenomas (n = 3198)
15 the admissions, more common in survivors and low-risk admissions than in nonsurvivors and high-risk a
17 ears or immunocompromised [HIV-infected]) or low risk (aged 3 years or older and immunocompetent [HIV
18 dose naltrexone may represent a low-cost and low-risk alternative or adjunct in the treatment of HHD.
19 fied fewer patients with renal impairment as low risk and more as high risk, but with lower specifici
20 d 50 to 59 years, 88% (211 of 240) with very-low-risk and 68% (351 of 518) with low-risk disease chos
22 More important, the use of observation for low-risk and high-risk patients with prostate cancer is
25 identified two groups of patients with IPF (low-risk and high-risk), with significant differences in
27 ality, identifying patients at both high and low risk, and better correlated with follow-up renal fun
30 38%) of 65 patients were classified as being low-risk, and the probability of being non-dysplastic wa
31 ncreased risk for coprevalent disease versus low-risk asymptomatic contacts (14 [6%] of 224 vs 27 [2%
33 young adulthood, whereas disparities between low-risk blacks and whites were related to differences i
39 162 (35%) of 468 of patients fell into the low-risk category and the probability of being a true no
40 The majority of readmissions were because of low-risk chest pain that did not require any interventio
45 ermined: a high-risk, a moderate-risk, and a low-risk cluster (88.97%, 1.49%, 9.54% in 2009 and 82.42
49 o (1.58 million), NS-colo (1.22 million), or low-risk comparator procedures (joint injection, aspirat
51 ia (n = 8; excluded from survival analysis); low risk/completely necrotic (n = 7; zero relapses), int
52 ion of nontransplanted CKD patients and with low-risk control pregnancies, observed in Italy the new
53 ), 610 live-born singletons in CKD, and 1418 low-risk controls recruited in 2 large Italian Units in
58 5% CI, 2.8 to 25.6) but not among those with low-risk disease (absolute difference, 0.7 percentage po
60 the estimated probability of observation for low-risk disease varied impressively (mean, 27.8%; range
64 atric vaccination would reduce the number of low-risk elderly influenza cases to a greater extent tha
65 eness threshold of pound15 000 per QALY, the low-risk elderly seasonal vaccination programme will cea
66 greater extent than would vaccination of the low-risk elderly themselves if the elderly uptake is ach
67 substantial uncertainty exists as to whether low-risk elderly vaccination remains cost-effective, dri
68 , a strategy based on eliminating testing in low-risk farms resulted in a 40% reduction in sampling e
69 management and oral antibiotics were safe in low-risk FN with no infection-related mortality observed
70 ly benign clinical course, associated with a low risk for advanced heart failure symptoms, other dise
71 factors (CVRFs) is traditionally considered low risk for atherosclerosis; however, individuals witho
72 s among exceptional responders to NCT with a low risk for axillary metastases when breast pCR is docu
74 bolysis should be considered for patients at low risk for bleeding who have limb-threatening thrombos
76 ty of reporting (79 [28%] of 282), perceived low risk for injury (56 [20%] of 282), noncontaminated n
78 atory response syndrome (SIRS) and sepsis at low risk for organ dysfunction and death is a major clin
79 men: one predominantly Caucasian (n = 39) at low risk for PTB, the second predominantly African Ameri
80 e to identify patients with GNB infection at low risk for resistance to piperacillin-tazobactam (PT),
81 tion models to identify survivors at high or low risk for subsequent CNS tumors and validated these m
82 ify survivors of childhood cancer at high or low risk for subsequent CNS tumors on the basis of genet
83 ing of a structurally normal heart carries a low risk for sudden cardiac death; accordingly, there is
84 ied 17% of patients with renal impairment as low risk for the primary outcome (negative predictive va
85 on to be distinguished from HRLs that are at low risk for upgrade to cancer at surgery and thus could
87 if those categorized with the model to be at low risk for upgrade were surveilled and the remainder w
90 erm line (GL) were classified as oncogenetic low risk (gLoR; n = 111), whereas those with N/F GL and
92 t the study population involved a relatively low risk group in a previously well-screened and treated
94 CI, 0.52-0.78, respectively), but not in the low-risk group (risk ratio, 1.278; 95% CI, 0.888-1.839).
95 a trend that indicates that patients in the low-risk group could be at greater risk of suffering har
98 17115 men with very-low-risk (subset of the low-risk group) (clinical stage, T1c; Gleason score, </=
99 es), low-risk (including all men in the very-low-risk group) (T1-T2; Gleason score, </=6; and PSA, <1
100 (intermediate-risk group, n=36), and 84.4% (low-risk group, n=202), and it provided greater net clin
105 ce in median survival time between high- and low-risk groups (13.8 vs 10.7 years, respectively; P < .
107 lative incidences at age 50 years among CCSS low-risk groups were < 5%, compared with approximately 2
108 s in the ENTHUSE 33 trial into high-risk and low-risk groups with significantly different overall sur
110 e (z score, -0.52 [95% CI, -0.71 to -0.33]), low risk had the next best cost score (z score, -0.18 [9
111 gh risk (hazard ratio, 2.830; P </= .001) or low risk (hazard ratio, 0.323; P </= .001) of experienci
113 We conducted a cross-sectional study in low-risk health care workers (HCWs) at a single U.S. cen
114 n-specialists rapidly identify and de-label "low-risk" hospitalized patients with a label of PenA the
115 he prevalence of any high-risk HPV types and low-risk HPV types (mutually exclusive of high-risk HPV)
120 The misclassification of these patients as "low risk," in combination with the low sensitivity of qu
121 ancer length in </=4 positive biopsy cores), low-risk (including all men in the very-low-risk group)
128 infants at high familial risk of ASD and 42 low-risk infants, we show that hyperexpansion of the cor
129 d on the pro-arrhythmia risk classification (Low risk, Intermediate risk, or High risk) established r
133 re classified as high-risk (LOH-positive) or low-risk (LOH-negative) patients based on their LOH prof
135 M for the identification of patients at very low risk (<5%) of having varices needing treatment (VNT)
137 (MBGrp3-HR [n=65] and MBGrp4-HR [n=85]) and low-risk (MBGrp3-LR [n=50] and MBGrp4-LR [n=73]) subgrou
138 enriched in high-risk MDS (in comparison to low-risk MDS), TP53, GATA2, KRAS, RUNX1, STAG2, ASXL1, Z
140 The 2.5-year risks of tuberculosis in the low-risk, medium-risk, and high-risk groups were, respec
141 The 10-year risks of tuberculosis in the low-risk, medium-risk, and high-risk groups were, respec
142 ul observation are options for patients with low-risk micrometastatic disease, with due consideration
143 sisted 360-degree trabeculotomy is a useful, low-risk, modestly successful initial surgical treatment
145 ant ovulating (n = 20) and high- (n = 9) and low-risk (n = 16) pregnant women to probes of varying si
146 ficiaries, 547 practices were categorized as low risk (neither high social nor high medical risk) (me
149 ex > 50%, cold ischemia time > 24 hours) and low-risk (not having any risk factors, comprising approx
151 lly lower mortality (odds ratios high versus low risk of 5-8 [ADHERE] and 11-18 [GWTG] across time po
153 V-infected patients who are healthy and have low risk of AIDS-related outcomes should be included abs
156 nce generation was judged to be adequate (at low risk of bias) in 32% ( n = 173) of trials, and basel
164 er transplant recipients, including those at low risk of bleeding or high risk of thromboembolic comp
166 three groups: high risk, moderate risk, and low risk of cardiac events, according to cardiovascular
167 se of expensive antiemetics in patients with low risk of chemotherapy-induced nausea and vomiting.
169 rally not cost-effective among patients with low risk of CNV, including those with no or few risk fac
170 ptimal cut-off scores to identify persons at low risk of complications were as follows: CP <5; MELD <
178 this augmentation can be accomplished with a low risk of exacerbation of psychosis and adverse effect
179 he wider reef network, (2) have a relatively low risk of exposure to disturbances so that they are li
180 sociated with high BMD, high SM, low BR, and low risk of fractures [HR (95% CI) for osteoporotic frac
181 g on release by identifying those who are at low risk of future violent offending, and those at high
182 merism without toxic conditioning and with a low risk of graft versus host disease is a visionary but
183 admission, and identification of patients at low risk of harm, who are therefore suitable for outpati
186 6% had normal diastolic function and were at low risk of HF hospitalization or death (1%/y over a mea
189 sized clinical low-risk group did not have a low risk of IBTR without RT, and RT reduced the rate of
190 lementation on birth outcomes among women at low risk of ID and the potential mechanisms for adverse
192 n-malarial, low-breastfeeding setting with a low risk of mother-to-child transmission of HIV is uncle
194 The V3-specific IgG binding that predicted low risk of mother-to-child-transmission (MTCT) was depe
195 tion of less than 5 ng/L identified those at low risk of myocardial infarction or cardiac death withi
196 an LVEF >/=40% at increased risk of SCD and low risk of nonsudden death who may benefit from implant
197 Findings were confirmed in subjects with a low risk of preclinical Alzheimer disease indexed by the
198 markers to identify a group of patients with low risk of progression suitable for non-endoscopic foll
199 be used to determine a group of patients at low risk of progression, for whom endoscopy could be avo
200 Lactobacillus crispatus was associated with low risk of PTB in both cohorts, while Lactobacillus ine
203 high relaxivity (r 1 = 14.06 mM(-1) s(-1) ), low risk of release of Gd ions, and NIR-triggered drug r
205 cellent in vitro and in vivo activities, and low risk of toxicity profile except for the inhibition o
207 risk for disease transmission (IRD) accept a low risk of window period infection, yet those who decli
208 ed studies generally with "low" to "probably low" risk of bias and rated the overall body of evidence
211 bphenotypes (SAMS) to classify patients into low-risk or high-risk groups based on the 52-gene signat
212 e 2 superiority trial of adult patients with low-risk or International Prognostic Scoring System inte
214 increase in CKD events compared to those at low risk; participants at high CKD risk had a 1.31-fold
215 f reporting showed that male sex (P = .009), low-risk patient (P < .0001), self injury (P = .010), tr
216 ore (FRS); drains were omitted in negligible/low risk patients and drain fluid amylase (DFA) was meas
218 HCC patients into prognostic subgroups, with low-risk patients (<10 points) demonstrating excellent m
220 rs of studies provided data on the number of low-risk patients (no new ischemia on ECG and hs-cTnT me
222 re urgently needed to avoid overtreatment of low-risk patients and to prioritize alternative approach
223 s was used to discriminate between high- and low-risk patients and to select the most important progn
225 ients, and 378 890 (95% CI, 205 130-610 210) low-risk patients eligible for transcatheter aortic valv
229 blood cell count, >10 x 10(9)/L), as well as low-risk patients who experienced leukocytosis during in
239 In the 43 studies of HCV mono-infected "low-risk" patients (n = 7969) the pooled recurrence rate
242 ysis or embolectomy is reasonable, while for low-risk PE, anticoagulation alone is often chosen.
243 ociated with subsequent renal dysfunction in low-risk pediatric patients, especially in those older t
245 ary endpoint, small-duct PSC characterized a low-risk phenotype in both sexes (adjusted HR for men, 0
246 1732 (19%) positron emission tomographies at low-risk physiological severity CFR >/=2.3 to CFR <2.0,
247 ong with application of an m-HS identified a low-risk population that might be able to be directly di
252 6% and 59%, respectively, were assigned to a low-risk profile by the 70-GS (kappa, 0.02; 95% CI, -0.0
253 , and generic pharmacological compounds with low-risk profiles that are already in routine clinical u
254 mong patients who had 2 (n=355) or 3 (n=193) low-risk prognostic features at follow-up, including a c
255 lance has become the dominant management for low-risk prostate cancer among men in Sweden, with the h
256 % (380 of 665) to 91% (939 of 1027) for very-low-risk prostate cancer and from 40% (1159 of 2895) to
259 apy, a novel tissue-preserving treatment for low-risk prostate cancer, has shown favourable safety an
260 40% (1159 of 2895) to 74% (1951 of 2644) for low-risk prostate cancer, with the strongest increase oc
261 e (AS) is increasingly accepted for managing low-risk prostate cancer, yet there is no consensus abou
264 ted in the first trimester of pregnancy from low-risk, public maternity clinics in metropolitan Melbo
267 6] years), with 10.8% eligible for immediate low-risk reverse triage and 13.2% for discharge by 96 ho
268 of most SAEs was manageable, demonstrating a low-risk safety profile for IS collection even among sev
269 d Facebook may be an overlooked high-return, low-risk science outreach tool in which scientists can p
271 tional longitudinal study of fetal growth in low-risk singleton pregnancies of women of high or middl
272 perficial or nodular basal cell carcinoma at low-risk sites in our noninferiority randomized controll
274 gnificantly decreased, and the percentage of low-risk SPECT tests increased despite decreased SPECT u
275 particularly prognostic among patients with low-risk SSIGN tumors (HR, 6.1; 95% CI, 3.4 to 11.1; P <
276 sent in 2,815 of the 2,823 patients assigned low-risk status (NPV, 99.7% [95% CI: 99.4%-99.9%]).
279 tively low dose of celecoxib administered to low-risk subjects is associated with approximately the s
281 shown to effectively identify a substantial low-risk subset of patients possibly safe for early disc
282 cluding 4693, 15403, and 17115 men with very-low-risk (subset of the low-risk group) (clinical stage,
283 ost 80% of all tests performed in 2012 had a low-risk summed stress score compared with 29% in 1991 (
285 Intraoperative (18)F-FDG CLI is a promising, low-risk technique for intraoperative assessment of tumo
288 s novel antibacterial mode of action holds a low risk to induce bacterial resistance, and provides va
291 ofetal proteins and stem-cell markers, while low-risk tumors had low lin-28 homolog B and lethal-7 ex
293 for each method separated the same groups of low-risk (volume </= cutoff) from high-risk patients (vo
294 for Research and Treatment of Cancer status (low risk vs high risk), line of therapy (second line vs
295 ity facilitated stable energetic rewards and low risk, while weak fidelity facilitated high rewards a
296 observation alone after nephrectomy in very low-risk Wilms tumor (defined as stage I favorable histo
297 e AREN0532 study enrolled patients with very low-risk Wilms tumor confirmed by central review of path
298 pansion of an observation alone strategy for low-risk Wilms tumor incorporating both clinical feature
300 ailability of CAC data in a sizable group of low-risk women from the general population together with
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。